ASTL and familial pancreatic carcinoma: These data demonstrate SAS1B is expressed in a majority of pancreatic cancers evaluated and is not detected in normal human pancreatic ductal epithelium, providing rationale for further investigation of SAS1B as a therapeutic target for the treatment of PDAC.